A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

PHASE2CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

November 29, 2022

Primary Completion Date

June 5, 2024

Study Completion Date

July 9, 2024

Conditions
Mild Cognitive ImpairmentMild DementiaAlzheimer's Disease
Interventions
DRUG

SAGE-718

Softgel lipid capsules.

DRUG

SAGE-718-matching Placebo

Softgel lipid capsules.

Trial Locations (39)

10312

Sage Investigational Site, Staten Island

11229

Sage Investigational Site, Brooklyn

14203

Sage Investigational Site, Buffalo

19001

Sage Investigational Site, Abington

22031

Sage Investigational Site, Fairfax

27607

Sage Investigational Site, Raleigh

30030

Sage Investigational Site, Decatur

31404

Sage Investigational Site, Savannah

32256

Sage Investigational Site, Jacksonville

32504

Sage Investigational Site, Pensacola

32789

Sage Investigational Site, Winter Park

33024

Sage Investigational Site, Hollywood

33155

Sage Investigational Site, Miami

33410

Sage Investigational Site, Palm Beach Gardens

33609

Sage Investigational Site, Tampa

37212

Sage Investigational Site, Nashville

38119

Sage Investigational Site, Memphis

60640

Sage Investigational Site, Chicago

63005

Sage Investigational Site, Chesterfield

68046

Sage Investigational Site, Papillion

75231

Sage Investigational Site, Dallas

77030

Sage Investigational Site, Houston

78731

Sage Investigational Site, Austin

80120

Sage Investigational Site, Englewood

83642

Sage Investigational Site, Meridian

85297

Sage Investigational Site, Gilbert

Sage Investigational Site, Phoenix

87109

Sage Investigational Site, Albuquerque

90808

Sage Investigational Site, Long Beach

91403

Sage Investigational Site, Sherman Oaks

92123

Sage Investigational Site, San Diego

92374

Sage Investigational Site, Redlands

94549

Sage Investigational Site, Lafayette

96817

Sage Investigational Site, Honolulu

02129

Sage Investigational Site, Charlestown

01844

Sage Investigational Site, Methuen

08755

Sage Investigational Site, Toms River

00961

Sage Investigational Site, Bayamón

00935

Sage Investigational Site, Rio Piedras

All Listed Sponsors
lead

Supernus Pharmaceuticals, Inc.

INDUSTRY